{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:02:49Z","timestamp":1787025769338,"version":"build-2736575974"},"reference-count":22,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>Paroxysmal sympathetic hyperactivity (PSH) is a complication of severe traumatic or hypoxic brain injury characterized by transient episodes of tachycardia, tachypnea, hypertension, hyperthermia, diaphoresis, and\/or dystonic posturing. Posttraumatic \"sympathetic storms\" are associated with poor outcomes. PSH rarely occurs after brain tumor resection in pediatric patients; only 4 cases have been published since 1929. Thus, the authors sought to report their experience with postcraniotomy PSH in pediatric brain tumor patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS<\/jats:title>\n                    <jats:p>A retrospective study of patients younger than 18 years of age who underwent craniotomy for brain tumor resection at a single center by a single surgeon over a 7-year period was performed. A clinical diagnosis of postoperative PSH was recorded. Recorded outcomes included the interval between surgery and initiation of cytotoxic therapy, need for long-term CSF diversion, length of hospital stay, and survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Of the 150 patients who were included for analysis, 4 patients were diagnosed with postoperative PSH for an overall occurrence of 2.7%. PSH patients were younger than non-PSH patients (1.8 \u00b1 0.4 years vs 9.2 \u00b1 5.3 years, p = 0.010) and tended to have intraventricular tumors close to the thalamus, basal ganglia, and\/or brainstem. PSH patients experienced longer hospital admissions (44.3 \u00b1 23.4 days vs 6.8 \u00b1 9.4 days, p = 0.001), a shorter interval between surgery and initiation of cytotoxic cancer-directed therapy (14.3 \u00b1 8.0 days vs 90.7 days \u00b1 232.9 days, p = 0.011), and increased need for long-term CSF diversion compared with non-PSH patients (75% vs 25%, p = 0.005). At the last follow-up, 50% of PSH patients had died compared with 13% of non-PSH patients (p = 0.094).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>PSH is a rare postoperative complication that may affect young children with periventricular tumors and is associated with poorer clinical outcomes. Increasing awareness of this condition is vital to improving patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/2022.12.peds22369","type":"journal-article","created":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T07:00:00Z","timestamp":1672988400000},"page":"282-289","source":"Crossref","is-referenced-by-count":6,"title":["Weathering the storm: a single-institution experience with paroxysmal sympathetic hyperactivity after brain tumor resection in pediatric patients"],"prefix":"10.3171","volume":"31","author":[{"given":"Samantha M.","family":"Bouchal","sequence":"first","affiliation":[{"name":"Mayo Clinic Alix School of Medicine, Rochester; and"},{"name":"Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan M.","family":"Naylor","sequence":"additional","affiliation":[{"name":"Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Daniels","sequence":"additional","affiliation":[{"name":"Department of Neurologic Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"issue":"17","key":"b1","series-title":"J Neurotrauma","first-page":"1515","article-title":"Paroxysmal sympathetic hyperactivity after acquired brain injury: consensus on conceptual definition, nomenclature, and diagnostic criteria","volume":"31","author":"Baguley IJ","year":"2014","unstructured":"Baguley IJ, Perkes IE, Fernandez-Ortega JF, Rabinstein AA, Dolce G, Hendricks HT. Paroxysmal sympathetic hyperactivity after acquired brain injury: consensus on conceptual definition, nomenclature, and diagnostic criteria. J Neurotrauma. 2014;31(17):1515\u20131520.24731076"},{"issue":"9","key":"b2","series-title":"Lancet Neurol","first-page":"721","article-title":"Paroxysmal sympathetic hyperactivity: the storm after acute brain injury","volume":"16","author":"Meyfroidt G","year":"2017","unstructured":"Meyfroidt G, Baguley IJ, Menon DK. Paroxysmal sympathetic hyperactivity: the storm after acute brain injury. Lancet Neurol. 2017;16(9):721\u2013729.28816118"},{"issue":"7","key":"b3","series-title":"Brain Dev","first-page":"621","article-title":"Transient dysautonomia in an acute phase of encephalopathy with biphasic seizures and late reduced diffusion","volume":"39","author":"Ichimiya Y","year":"2017","unstructured":"Ichimiya Y, Kaku N, Sakai Y,  Transient dysautonomia in an acute phase of encephalopathy with biphasic seizures and late reduced diffusion. Brain Dev. 2017;39(7):621\u2013624."},{"issue":"4","key":"b4","series-title":"J Pediatr Pharmacol Ther","first-page":"335","article-title":"Morphine: an effective abortive therapy for pediatric paroxysmal sympathetic hyperactivity after hypoxic brain injury","volume":"20","author":"Raithel DS","year":"2015","unstructured":"Raithel DS, Ohler KH, Porto I, Bicknese AR, Kraus DM. Morphine: an effective abortive therapy for pediatric paroxysmal sympathetic hyperactivity after hypoxic brain injury. J Pediatr Pharmacol Ther. 2015;20(4):335\u2013340.26380574"},{"issue":"2","key":"b5","series-title":"J Pediatr","first-page":"277","article-title":"Diencephalic autonomic epilepsy caused by a neoplasm","volume":"83","author":"Solomon GE","year":"1973","unstructured":"Solomon GE. Diencephalic autonomic epilepsy caused by a neoplasm. J Pediatr. 1973;83(2):277\u2013280.4717587"},{"issue":"2","key":"b6","series-title":"Arch Neurol Psychiatry","first-page":"358","article-title":"Diencephalic autonomic epilepsy","volume":"22","author":"Penfield W","year":"1929","unstructured":"Penfield W. Diencephalic autonomic epilepsy. Arch Neurol Psychiatry. 1929;22(2):358\u2013374."},{"issue":"7","key":"b7","series-title":"J Neurotrauma","first-page":"1364","article-title":"Paroxysmal sympathetic hyperactivity after traumatic brain injury: clinical and prognostic implications","volume":"29","author":"Fernandez-Ortega JF","year":"2012","unstructured":"Fernandez-Ortega JF, Prieto-Palomino MA, Garcia-Caballero M, Galeas-Lopez JL, Quesada-Garcia G, Baguley IJ. Paroxysmal sympathetic hyperactivity after traumatic brain injury: clinical and prognostic implications. J Neurotrauma. 2012;29(7):1364\u20131370.22150061"},{"issue":"6","key":"b8","series-title":"Clin Rehabil","first-page":"545","article-title":"Brain injury severity and autonomic dysregulation accurately predict heterotopic ossification in patients with traumatic brain injury","volume":"21","author":"Hendricks HT","year":"2007","unstructured":"Hendricks HT, Geurts AC, van Ginneken BC, Heeren AJ, Vos PE. Brain injury severity and autonomic dysregulation accurately predict heterotopic ossification in patients with traumatic brain injury. Clin Rehabil. 2007;21(6):545\u2013553.17613585"},{"issue":"3","key":"b9","series-title":"Pediatr Crit Care Med","first-page":"252","article-title":"Paroxysmal sympathetic hyperactivity after severe traumatic brain injury in children: prevalence, risk factors, and outcome","volume":"20","author":"Alofisan TO","year":"2019","unstructured":"Alofisan TO, Algarni YA, Alharfi IM,  Paroxysmal sympathetic hyperactivity after severe traumatic brain injury in children: prevalence, risk factors, and outcome. Pediatr Crit Care Med. 2019;20(3):252\u2013258.30489486"},{"issue":"6","key":"b10","series-title":"Pediatr Neurosurg","first-page":"301","article-title":"Treatment progress of paroxysmal sympathetic hyperactivity after acquired brain injury","volume":"50","author":"Feng Y","year":"2015","unstructured":"Feng Y, Zheng X, Fang Z. Treatment progress of paroxysmal sympathetic hyperactivity after acquired brain injury. Pediatr Neurosurg. 2015;50(6):301\u2013309.26352612"},{"issue":"2","key":"b11","series-title":"Neurocrit Care","first-page":"293","article-title":"A critical review of the pathophysiology of dysautonomia following traumatic brain injury","volume":"8","author":"Baguley IJ","year":"2008","unstructured":"Baguley IJ, Heriseanu RE, Cameron ID, Nott MT, Slewa-Younan S. A critical review of the pathophysiology of dysautonomia following traumatic brain injury. Neurocrit Care. 2008;8(2):293\u2013300.17968518"},{"issue":"4","key":"b12","series-title":"Pediatr Neurol","first-page":"742","article-title":"Sympathetic storms in a child with a midbrain glioma: a variant of diencephalic seizures","volume":"21","author":"Goh KY","year":"1999","unstructured":"Goh KY, Conway EJ, DaRosso RC, Muszynski CA, Epstein FJ. Sympathetic storms in a child with a midbrain glioma: a variant of diencephalic seizures. Pediatr Neurol. 1999;21(4):742\u2013744."},{"issue":"2","key":"b13","series-title":"Indian J Med Paediatr Oncol","first-page":"254","article-title":"Paroxysmal sympathetic hyperactivity\u2014an under-recognized entity in pediatric brain tumors: case report and review of literature","volume":"41","author":"Yamini Krishnan BS","year":"2020","unstructured":"Yamini Krishnan BS, Shamsudheen C. Paroxysmal sympathetic hyperactivity\u2014an under-recognized entity in pediatric brain tumors: case report and review of literature. Indian J Med Paediatr Oncol. 2020;41(2):254\u2013256."},{"issue":"1","key":"b14","series-title":"Arch Neurol Psychiatry","first-page":"37","article-title":"Hypothalamic attacks with thalamic lesion: physiologic and psychologic considerations","volume":"54","author":"Engel GL","year":"1945","unstructured":"Engel GL, Aring CD. Hypothalamic attacks with thalamic lesion: physiologic and psychologic considerations. Arch Neurol Psychiatry. 1945;54(1):37\u201343."},{"issue":"22","key":"b15","series-title":"J Neurotrauma","first-page":"1897","article-title":"Clinical scales for paroxysmal sympathetic hyperactivity in pediatric patients","volume":"31","author":"Pozzi M","year":"2014","unstructured":"Pozzi M, Locatelli F, Galbiati S, Radice S, Clementi E, Strazzer S. Clinical scales for paroxysmal sympathetic hyperactivity in pediatric patients. J Neurotrauma. 2014;31(22):1897\u20131898.24964056"},{"key":"b16","article-title":"Integrated Development for R","author":"RStudio","year":"2020","unstructured":"RStudio. Integrated Development for R. PBC; 2020."},{"key":"b17","series-title":"World Neurosurg","first-page":"e218","article-title":"Beware: sialadenitis as a rare post neurosurgical complication: a single-institution clinical case series","volume":"162","author":"Yagnik KJ","year":"2022","unstructured":"Yagnik KJ, Naylor RM, Carlson ML, Welch TL, Van Gompel JJ. Beware: sialadenitis as a rare post neurosurgical complication: a single-institution clinical case series. World Neurosurg. 2022;162:e218\u2013e224.35259503"},{"issue":"7","key":"b18","series-title":"Neurol Res","first-page":"680","article-title":"Paroxysmal sympathetic hyperactivity in the neurological intensive care unit","volume":"29","author":"Rabinstein AA","year":"2007","unstructured":"Rabinstein AA. Paroxysmal sympathetic hyperactivity in the neurological intensive care unit. Neurol Res. 2007;29(7):680\u2013682.18173907"},{"issue":"8","key":"b19","series-title":"Curr Neurol Neurosci Rep","first-page":"370","article-title":"Paroxysmal sympathetic hyperactivity after acute brain injury","volume":"13","author":"Choi HA","year":"2013","unstructured":"Choi HA, Jeon SB, Samuel S, Allison T, Lee K. Paroxysmal sympathetic hyperactivity after acute brain injury. Curr Neurol Neurosci Rep. 2013;13(8):370.23780802"},{"issue":"2","key":"b20","series-title":"Curr Treat Options Neurol","first-page":"151","article-title":"Treatment of paroxysmal sympathetic hyperactivity","volume":"10","author":"Rabinstein AA","year":"2008","unstructured":"Rabinstein AA, Benarroch EE. Treatment of paroxysmal sympathetic hyperactivity. Curr Treat Options Neurol. 2008;10(2):151\u2013157.18334137"},{"issue":"2","key":"b21","series-title":"J Head Trauma Rehabil","first-page":"117","article-title":"Paroxysmal sympathetic hyperactivity in pediatric rehabilitation: pathological features and scheduled pharmacological therapies","volume":"32","author":"Pozzi M","year":"2017","unstructured":"Pozzi M, Conti V, Locatelli F,  Paroxysmal sympathetic hyperactivity in pediatric rehabilitation: pathological features and scheduled pharmacological therapies. J Head Trauma Rehabil. 2017;32(2):117\u2013124.27603764"},{"issue":"1","key":"b22","series-title":"J Pediatr Intensive Care","first-page":"64","article-title":"Management of paroxysmal sympathetic hyperactivity with dexmedetomidine and propranolol following traumatic brain injury in a pediatric patient","volume":"9","author":"Branstetter JW","year":"2020","unstructured":"Branstetter JW, Ohman KL, Johnson DW, Gilbert BW. Management of paroxysmal sympathetic hyperactivity with dexmedetomidine and propranolol following traumatic brain injury in a pediatric patient. J Pediatr Intensive Care. 2020;9(1):64\u201369."}],"container-title":["Journal of Neurosurgery: Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/31\/4\/article-p282.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/31\/4\/article-p282.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-pediatr\/31\/4\/article-p282.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T08:03:57Z","timestamp":1733472237000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-pediatr\/31\/4\/article-p282.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,1]]},"references-count":22,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3171\/2022.12.peds22369","relation":{},"ISSN":["1933-0707","1933-0715"],"issn-type":[{"value":"1933-0707","type":"print"},{"value":"1933-0715","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,1]]}}}